Biohaven Pharmaceuticals, Inc. is a biopharmaceutical company based in Connecticut. Its disclosed lobbying focuses on drug-approval rules for rare diseases and neurodegenerative conditions, including regulatory flexibilities related to the Act of ALS and on patent exclusivity for small-molecule drugs. It has reported four filings and about $240,000 in lobbying since the filings listed.
Show the dominant industry call, how mixed the client looks, and the allocation across the top labeled sectors.
Annual totals based on disclosed filing amounts.
Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.
The lobbying registrants handling this client, ranked by disclosed filing amounts.
Lobbyists are ranked by appearances and an equal share of each filing's reported amount.
ALEX PINSON
The latest disclosures for this client.
DLA PIPER LLP (US)
Q3DLA PIPER LLP (US)
Q2The entities named in disclosed activities are the clearest available signal for where the client is aiming attention.
DLA PIPER LLP (US)
KARINA LYNCH
DLA PIPER LLP (US)
VINCENT SARUBBI jr
DLA PIPER LLP (US)
mr JAMIE ALEXEI GREGORIAN
DLA PIPER LLP (US)
DLA PIPER LLP (US)
Q1DLA PIPER LLP (US)
Q4DLA PIPER LLP (US)
Q3DLA PIPER LLP (US)
Q2DLA PIPER LLP (US)
Q1